Cat. No. |
Product Name |
Information |
PC-61567 |
PF-3893787
|
PF-3893787 (ZPL 3893787) is a potent and selective H4 receptor antagonist with binding Ki of 2.4 nM. |
PC-60533 |
Seliforant
Histamine H4 antagonist
|
Seliforant (SENS-111, SENS111) is a novel potent, selective histamine H4 receptor antagonist. |
PC-45369 |
Decloxizine
Histamin H1 antagonist
|
Decloxizine (UCB-1402, NSC-289116) is a potent histamine 1 (H1) receptor antagonist. |
PC-42909 |
Pitolisant
H3 receptor antagonist
|
Pitolisant (Tiprolisant; BF-2649; BF 2.649) is a potent and selective antagonist of H3 receptor with Ki/EC50 of 0.16/1.5 nM. |
PC-21121 |
SB-271046
5-HT6 antagonist
|
SB-271046 is a potent, selective and orally active 5-HT6 receptor antagonist, potently displaces [(3)H]-LSD and [(125)I]-SB-258585 from human 5-HT6 receptors recombinantly expressed in HeLa cells with pKi 8.92 and 9.09 respectively. |
PC-20926 |
JNJ-10191584
Histamin H4 antagonist
|
JNJ-10191584 (VUF6002) is a potent, highly selective, orally active histamine H(4) receptor antagonist with binding Ki of 26 nM, 540-fold selectivity to H4 receptor over H3 receptor. |
PC-20925 |
JNJ 10191584 maleate
Histamin H4 antagonist
|
JNJ-10191584 (VUF6002) is a potent, highly selective, orally active histamine H(4) receptor antagonist with binding Ki of 26 nM, 540-fold selectivity to H4 receptor over H3 receptor. |
PC-49738 |
UR-MB-69
H2 receptor agonist
|
UR-MB-69 is a potent agonist of histamine H2 receptor (H2R) dopamine receptor D3R with pKi of 8.69 and 8.06, respectively. |
PC-49737 |
UR-MB-158
H2 receptor agonist
|
UR-MB-158 is a a potent, selective H2 receptor agonist. |
PC-49736 |
UR-Po563
H2 receptor agonist
|
UR-Po563 is a potent, selective H2 receptor agonist with pKi of 7.75, >400-fold selectivity over H1R/H3R/H4R. |
PC-73211 |
PF-04995274
5-HT4R agonist
|
PF-04995274 is a potent, selective, orally active and partial serotonin 4 receptor (5-HT4R) agonist with Ki of 0.15-0.46 nM. |
PC-72278 |
TASP0410461
H3R antagonist
|
TASP0410461 is a potent, selective histamine H3 receptor antagonist/inverse agonist. |